Comparison

Rosiglitazone European Partner

Item no. TMO-T0334-25mg
Manufacturer TargetMol
CASRN 122320-73-4
Amount 25 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg
Category
Type Molecules
Specific against other
Citations 1. Pfützner A, et al. Vasc Health Risk Manag. 2007; 3(2):211-20.
Smiles C(C1SC(=O)NC1=O)C2=CC=C(OCCN(C)C3=CC=CC=N3)C=C2
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias BRL49653
Shipping Condition Cool pack
Available
Manufacturer - Targets
PPAR|||Autophagy|||Ferroptosis|||TRP/TRPV Channel
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
357.43
Description
Rosiglitazone (BRL49653) is a PPARγ agonist, TRPC5 activator, and TRPM3 inhibitor with oral activity. Rosiglitazone is also a hypoglycemic agent and a thiazolidinedione insulin sensitizer.
Pathways
Metabolism|||DNA Damage/DNA Repair|||Membrane transporter/Ion channel|||Autophagy|||Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close